Ortin Global Limited (BOM:539287)
14.26
+0.67 (4.93%)
At close: Feb 12, 2026
Ortin Global Revenue
Ortin Global had revenue of 140.00K INR in the quarter ending September 30, 2025, a decrease of -73.33%. This brings the company's revenue in the last twelve months to 1.74M, down -73.31% year-over-year. In the fiscal year ending March 31, 2025, Ortin Global had annual revenue of 3.43M, down -84.61%.
Revenue (ttm)
1.74M
Revenue Growth
-73.31%
P/S Ratio
70.08
Revenue / Employee
579.00K
Employees
3
Market Cap
121.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.43M | -18.84M | -84.61% |
| Mar 31, 2024 | 22.26M | -38.08M | -63.11% |
| Mar 31, 2023 | 60.34M | -21.97M | -26.69% |
| Mar 31, 2022 | 82.31M | 633.62K | 0.78% |
| Mar 31, 2021 | 81.67M | -1.89B | -95.86% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sunrest Lifescience | 520.34M |
| Cian Healthcare | 232.80M |
| Beryl Drugs | 176.65M |
| Unjha Formulations | 148.12M |
| Norris Medicines | 72.84M |
| Hamps Bio | 71.20M |
| Desh Rakshak Aushdhalaya | 62.53M |
| Colinz Laboratories | 58.40M |